The LLR TAP IcICLLe trial assessing biological response to ibrutinib in CLL: Immediate disease redistribution precedes cell cycle arrest by 2 weeks with reduced bone marrow infiltration by 6 months

Kristian Brock

Research output: Contribution to conference (unpublished) › Abstract › peer-review

Fingerprint

Dive into the research topics of 'The LLR TAP IcICLLe trial assessing biological response to ibrutinib in CLL: Immediate disease redistribution precedes cell cycle arrest by 2 weeks with reduced bone marrow infiltration by 6 months'. Together they form a unique fingerprint.

Medicine & Life Sciences